#Pennsylvania-based#document transformation#pharmaceutical#pharmaceutical

Adlib hires John Hanrahan as principal, Life Sciences Practice

Adlib has appointed John Hanrahan as the Principal, Life Sciences Practice. Pennsylvania-based Hanrahan will be responsible for directing the life scie...

Admin
|Jan 25|magazine6 min read

Adlib has appointed John Hanrahan as the Principal,  Life Sciences Practice. Pennsylvania-based Hanrahan will be responsible for directing the life sciences practice at Adlib to further expand the company’s present stronghold for document transformation and rendering in the Life Sciences and healthcare markets.

Mr. John has over 20 years of experience as a team builder and technical evangelist, specializing in solutions and best practices for the life sciences industry, including all aspects of pharmaceutical and biotech industries.

John holds an MBA in Pharmaceutical Business from University of the Sciences, the first pharmaceutical college in North America, Philadelphia College of Pharmacy, and the same school attended by founding pharmaceutical giants such as Eli Lilly, Rorer, Warner-Lambert, McNeingl, Burroughs and Wyeth.

Before joining Adlib, he spent 14 years with EMC/Documentum, where he worked with customers to create Life Sciences solutions aimed to increase the efficiency across the entire product life cycle from the drug discovery to regulation submissions and commercialization.

Hanrahan said, “I’m pleased to join Adlib, which produces the industry de facto standard for creating departmental publishing solutions that are submission-ready.” He also said, “I’m eagerly anticipating working with our clients as we create a new and enhanced publishing solution for Life Sciences. I also look forward to working with our many partners such as CSC, Dassault, EMC, InfoTehna, Innovocommerce, LORENZ, Microsoft, NextDocs, OpenText, MasterControl, and Qumas, to further complement their solutions as we jointly deliver greater value to our clients.”

Adlib helps the life sciences industry improve profitability by reducing time to market and decrease the cost inherent in regulatory publishing.  

Its submission-ready PDF renditions eliminate the time-consuming and error-prone PDF rendering that is prevalent in medical device and pharmaceutical companies.

 Peter Duff, President and CEO of Adlib said, “John Hanrahan’s extensive industry experience and impressive reputation are well known throughout the Life Sciences community. Mr. Duff also said, “We have enjoyed great success with many tier one life sciences organizations, such as assisting Roche Diagnostics product lifecycle to meet FDA (21 CFR Part 11) with Adlib and Microsoft SharePoint integration for automated PDF rendering and publishing. We are relying on John Hanrahan’s direction to continue our dominance of the document-to-PDF industry, and to grow our business within document-intensive life sciences organizations.”